Please use this identifier to cite or link to this item:
https://accedacris.ulpgc.es/handle/10553/49964
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Antunes, N. T. | |
dc.contributor.author | Tavío, M. M. | |
dc.contributor.author | Mercier, P. | |
dc.contributor.author | Ayling, R. D. | |
dc.contributor.author | Al-Momani, W. | |
dc.contributor.author | Assunção, P. | |
dc.contributor.author | Rosales, R. S. | |
dc.contributor.author | Poveda, J. B. | |
dc.contributor.other | Poveda, Jose | |
dc.contributor.other | Rosales, Ruben | |
dc.contributor.other | Ayling, Roger | |
dc.contributor.other | APHA, Staff publications | |
dc.contributor.other | Rosales, Ruben S. | |
dc.date.accessioned | 2018-11-24T12:10:03Z | - |
dc.date.available | 2018-11-24T12:10:03Z | - |
dc.date.issued | 2007 | |
dc.identifier.issn | 0066-4804 | |
dc.identifier.uri | https://accedacris.ulpgc.es/handle/10553/49964 | - |
dc.description.abstract | MICs were determined for 15 antimicrobial agents against 37 Mycoplasma putrefaciens isolates. The most effective antimicrobial drug classes were the fluoroquinolones, the tetracyclines, the lincosamide lincomycin, and the macrolides. The susceptibility profile of the isolates correlated with the geographic origin. This is the first report of decreased susceptibility to the macrolides, lincomycin, and the tetracyclines in M. putrefaciens strains. | |
dc.publisher | 0066-4804 | |
dc.relation.ispartof | Antimicrobial Agents and Chemotherapy | |
dc.source | Antimicrobial Agents And Chemotherapy[ISSN 0066-4804],v. 51 (9), p. 3452-3454 | |
dc.subject.other | Caprine Mycoplasmosis | |
dc.subject.other | Acquired-Resistance | |
dc.subject.other | Hominis | |
dc.subject.other | Hyopneumoniae | |
dc.subject.other | Macrolides | |
dc.subject.other | Mastitis | |
dc.title | In vitro susceptibilities of Mycoplasma putrefaciens field isolates | |
dc.type | info:eu-repo/semantics/Article | es |
dc.type | Article | es |
dc.identifier.doi | 10.1128/AAC.00420-07 | |
dc.identifier.scopus | 35948938897 | |
dc.identifier.isi | 000249175400072 | |
dcterms.isPartOf | Antimicrobial Agents And Chemotherapy | |
dcterms.source | Antimicrobial Agents And Chemotherapy[ISSN 0066-4804],v. 51 (9), p. 3452-3454 | |
dc.contributor.authorscopusid | 57196635499 | |
dc.contributor.authorscopusid | 6701659492 | |
dc.contributor.authorscopusid | 16043419700 | |
dc.contributor.authorscopusid | 7003646717 | |
dc.contributor.authorscopusid | 21733505800 | |
dc.contributor.authorscopusid | 6701838348 | |
dc.contributor.authorscopusid | 8552025600 | |
dc.contributor.authorscopusid | 7005736558 | |
dc.description.lastpage | 3454 | |
dc.description.firstpage | 3452 | |
dc.relation.volume | 51 | |
dc.type2 | Artículo | es |
dc.identifier.wos | WOS:000249175400072 | |
dc.contributor.daisngid | 1398738 | |
dc.contributor.daisngid | 11940945 | |
dc.contributor.daisngid | 1088156 | |
dc.contributor.daisngid | 244836 | |
dc.contributor.daisngid | 2645353 | |
dc.contributor.daisngid | 1211232 | |
dc.contributor.daisngid | 907575 | |
dc.contributor.daisngid | 498394 | |
dc.identifier.investigatorRID | L-5987-2014 | |
dc.identifier.investigatorRID | A-5679-2013 | |
dc.identifier.investigatorRID | C-7567-2011 | |
dc.identifier.investigatorRID | E-6082-2010 | |
dc.identifier.investigatorRID | No ID | |
dc.contributor.wosstandard | WOS:Antunes, NT | |
dc.contributor.wosstandard | WOS:Tavio, MA | |
dc.contributor.wosstandard | WOS:Mercier, P | |
dc.contributor.wosstandard | WOS:Ayling, RD | |
dc.contributor.wosstandard | WOS:Al-Momani, W | |
dc.contributor.wosstandard | WOS:Assuncao, P | |
dc.contributor.wosstandard | WOS:Rosales, RS | |
dc.contributor.wosstandard | WOS:Poveda, JB | |
dc.date.coverdate | Septiembre 2007 | |
dc.identifier.ulpgc | Sí | es |
dc.description.jcr | 4,39 | |
dc.description.jcrq | Q1 | |
dc.description.scie | SCIE | |
item.fulltext | Sin texto completo | - |
item.grantfulltext | none | - |
crisitem.author.dept | GIR Investigación Básica y Aplicada en Ciencias de la Salud | - |
crisitem.author.dept | Departamento de Ciencias Clínicas | - |
crisitem.author.dept | GIR IUSA-ONEHEALTH1: Epidemiología, Medicina Preventiva Veterinaria y Zoonosis | - |
crisitem.author.dept | IU de Sanidad Animal y Seguridad Alimentaria | - |
crisitem.author.dept | Departamento de Patología Animal, Producción Animal, Bromatología y Tecnología de Los Alimentos | - |
crisitem.author.dept | GIR IUSA-ONEHEALTH1: Epidemiología, Medicina Preventiva Veterinaria y Zoonosis | - |
crisitem.author.dept | IU de Sanidad Animal y Seguridad Alimentaria | - |
crisitem.author.dept | Departamento de Patología Animal, Producción Animal, Bromatología y Tecnología de Los Alimentos | - |
crisitem.author.orcid | 0000-0002-1808-7461 | - |
crisitem.author.orcid | 0000-0003-3706-0181 | - |
crisitem.author.orcid | 0000-0002-9846-2427 | - |
crisitem.author.parentorg | Departamento de Ciencias Clínicas | - |
crisitem.author.parentorg | IU de Sanidad Animal y Seguridad Alimentaria | - |
crisitem.author.parentorg | IU de Sanidad Animal y Seguridad Alimentaria | - |
crisitem.author.fullName | Tavío Pérez, María Del Mar | - |
crisitem.author.fullName | Rosales Santana, Rubén Sebastián | - |
crisitem.author.fullName | Poveda Guerrero, José Bismarck | - |
Appears in Collections: | Artículos |
SCOPUSTM
Citations
10
checked on Mar 30, 2025
WEB OF SCIENCETM
Citations
11
checked on Mar 30, 2025
Page view(s)
93
checked on Sep 21, 2024
Google ScholarTM
Check
Altmetric
Share
Export metadata
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.